293 related articles for article (PubMed ID: 18947382)
1. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study.
Daubin C; Parienti JJ; Fradin S; Vabret A; Ramakers M; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
BMC Infect Dis; 2009 Sep; 9():157. PubMed ID: 19772586
[TBL] [Abstract][Full Text] [Related]
3. [The changes and clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease].
Chang C; Yao WZ; Chen YH; Liu ZY; Zhang XW
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jul; 29(7):444-7. PubMed ID: 17045042
[TBL] [Abstract][Full Text] [Related]
4. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
[TBL] [Abstract][Full Text] [Related]
5. [Value of serum procalcitonin in diagnosing bacterial lower respiratory tract infections in people with exacerbation of Chronic Obstructive Pulmonary Disease].
Chang C; Yao WZ; Chen YH; Liu ZY; Zhang XW
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):389-92. PubMed ID: 16892144
[TBL] [Abstract][Full Text] [Related]
6. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
[TBL] [Abstract][Full Text] [Related]
7. Factors predicting bacterial involvement in severe acute exacerbations of chronic obstructive pulmonary disease.
Nseir S; Cavestri B; Di Pompeo C; Diarra M; Brisson H; Lemyze M; Roussel-Delvallez M; Durocher A
Respiration; 2008; 76(3):253-60. PubMed ID: 18547944
[TBL] [Abstract][Full Text] [Related]
8. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
[TBL] [Abstract][Full Text] [Related]
9. The utility of initial procalcitonin and procalcitonin clearance for prediction of bacterial infection and outcome in critically ill patients with autoimmune diseases: a prospective observational study.
Shi Y; Peng JM; Hu XY; Wang Y
BMC Anesthesiol; 2015 Oct; 15():137. PubMed ID: 26446077
[TBL] [Abstract][Full Text] [Related]
10. Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD.
Corti C; Fally M; Fabricius-Bjerre A; Mortensen K; Jensen BN; Andreassen HF; Porsbjerg C; Knudsen JD; Jensen JU
Int J Chron Obstruct Pulmon Dis; 2016; 11():1381-9. PubMed ID: 27382274
[TBL] [Abstract][Full Text] [Related]
11. Early changes of procalcitonin predict bacteremia in patients with intensive care unit-acquired new fever.
Shi Y; DU B; Xu YC; Rui X; DU W; Wang Y
Chin Med J (Engl); 2013; 126(10):1832-7. PubMed ID: 23673095
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels.
So W; Simon MS; Choi JJ; Wang TZ; Williams SC; Chua J; Kubin CJ
Intern Emerg Med; 2022 Aug; 17(5):1405-1412. PubMed ID: 35277828
[TBL] [Abstract][Full Text] [Related]
13. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.
Daniels JM; Schoorl M; Snijders D; Knol DL; Lutter R; Jansen HM; Boersma WG
Chest; 2010 Nov; 138(5):1108-15. PubMed ID: 20576731
[TBL] [Abstract][Full Text] [Related]
14. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD.
Soler N; Esperatti M; Ewig S; Huerta A; Agustí C; Torres A
Eur Respir J; 2012 Dec; 40(6):1344-53. PubMed ID: 22523352
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
[TBL] [Abstract][Full Text] [Related]
16. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
[TBL] [Abstract][Full Text] [Related]
17. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note.
Falsey AR; Becker KL; Swinburne AJ; Nylen ES; Snider RH; Formica MA; Hennessey PA; Criddle MM; Peterson DR; Walsh EE
Int J Chron Obstruct Pulmon Dis; 2012; 7():127-35. PubMed ID: 22399852
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary disease.
Rammaert B; Verdier N; Cavestri B; Nseir S
Respirology; 2009 Sep; 14(7):969-74. PubMed ID: 19659517
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
[TBL] [Abstract][Full Text] [Related]
20. [Role of procalcitonin in the diagnosis of ventilator-associated pneumonia].
Liao XL; Jin XD; Kang Y; Deng YY; Zhang ZW; Zhou Y; Zhang ZW; Liu C; Yin WH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Mar; 22(3):142-5. PubMed ID: 20367902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
